"This book is essential reading for researchers of tobacco policy change. Too many studies simply complain that change is too slow because tobacco companies are too powerful and politicians lack the will to challenge them. This book goes much further, to help us understand not just industry strategy but the policy processes in which policy advocates engage, learn from each other, and help create essential global tobacco policy change." Paul Cairney, University of Stirling, UK "This book is rare in making genuinely significant contributions across both public health and policy studies. By focusing on the battle for standardised packs, it engagingly addresses one of the most prominent recent innovations in health policy that has relevance both beyond Europe and across multiple spheres of health policy. In doing so, it also offers an innovative analysis of the role of transnational corporations in policy transfer."Jeff Collin, University of Edinburgh, UK This book analyses the battle for standardised cigarette packaging ('plain packaging') in Europe, drawing on the concepts of multi-level governance and policy transfer. It analyses the strategies of policy makers, non-governmental organisations and transnational tobacco companies in attempting either to advance or to block the introduction of standardised packaging. Taking a global and multi-level approach, it analyses these struggles within European Union institutions, EU member states, and across jurisdictions, as NGOs and tobacco companies worked transnationally to counter each other. As well as presenting original empirical research detailing these policy battles, the book provides new theoretical insights into policy transfer processes, particularly within multi-level polities, showing how transnational corporations can have dramatic effects on these processes. The book will appeal equally to public health researchers, policy analysts and political scientists.

This book expands on and complements the burgeoning Brexit literature by placing the UK's vote to leave the EU in its longer historical and discursive contexts. It examines the embedded Euroscepticism, which has dominated British political discourse on the European project and the role of the UK within it for at least the last three decades. Brexit was the consequence of a consistent denigration of the European integration project in the public sphere in which the terrain, and the conceptual vocabulary, of debate were set by a dominant, right-wing Eurosceptic discourse. This framed the EU as inherently heterogeneous and antagonistic to the UK. The book examines how ideas of British exceptionalism, which underpin Eurosceptic discourses, are sustained and reproduced and offers an account of their enduring, affective power amongst the British population. It is in this context that it was possible for pro-Brexit campaigners to assemble and enthuse a new coalition of voters sufficient to deliver a 'leave' majority on 23 June 2016. This text will be of key interest to scholars and students of British, EU and European politics, the media and press, public opinion, political behaviour and nationalism studies.

The profound changes to the world economy since the late twentieth century have been characterised by a growth in the number and size of transnational corporations. In this context, there is now increasing evidence of unprecedented reversals in health indicators among populations around the world. Research in this area has focused on documenting the global health impacts arising from the economic activity of corporations. The challenge for public health researchers is to understand the ways in which corporations are regulated by, and participate in global health governance and implications for health and well-being across the globe. This book is an introductory guide to conducting research on the role of corporations in global health governance from a range of disciplinary perspectives and gives an overview of different approaches, methodologies and data sources. Also, for case studies providing interdisciplinary empirical analysis of the impact of corporations on global health and global health governance, see the partner volume: http://www.rowmaninternational.com/books/case-studies-on-corporations-and-global-health-governance

The profound changes to the world economy since the late twentieth century have been characterised by a growth in the number and size of transnational corporations. In this context, there is now increasing evidence of unprecedented reversals in health indicators among populations around the world. Research in this area has focused on documenting the global health impacts arising from the economic activity of corporations. The challenge for public health researchers is to understand the ways in which corporations are regulated by, and participate in global health governance and implications for health and well-being across the globe. This book is an introductory guide to conducting research on the role of corporations in global health governance from a range of disciplinary perspectives and gives an overview of different approaches, methodologies and data sources. Also, for case studies providing interdisciplinary empirical analysis of the impact of corporations on global health and global health governance, see the partner volume: http://www.rowmaninternational.com/books/case-studies-on-corporations-and-global-health-governance

“I can easily see this book being the ‘go-to’ text for students of global health. It provides a comprehensive overview of globalisation’s impact on health and wellbeing.� Professor David McCoy, United Nations University - International Institute for Global Health, Kuala Lumpur, Malaysia. “This book, which is based on rich and diverse empirical case-studies, highlights the importance of understanding global health as a multi-disciplinary field.� Haim Yacobi, Professor of Development Planning, Bartlett Development Planning Unit, University College London, UK  “This book is relevant for everyone that would like to have an overview of current issues of global health in the context of the globalization era.� Ari Probandari, Professor of Public Health at Universitas Sebelas Maret, Indonesia Global health challenges are evolving profoundly. Today public health practitioners must recognize the importance of global changes for human health and health policy at all levels. Fully revised and restructured, this ground-breaking title returns in its third edition to offer students and practitioners an accessible and contemporary exploration of globalization and global health.  The book includes critical reflection on global changes, with practical learning activities which help you explore the central debates. Chapters cover key issues, and emerging trends in global policy, such as: •Social change in the 21st century, including social media and technology •The emergence of global health governance and its colonial heritage •Trade and its implications on health, policy, and disease •Global environmental change including climate, biodiversity, and global policy responses  •Infectious disease including pandemic trends and global policy responses •Non-communicable diseases and the risks of alcohol, food, and tobacco •Governance and the state, including non-governmental actors  The third edition of Globalization and Global Health is an ideal resource for students of public health and health policy, public health practitioners and policy makers. Contributors: Carolyn Stephens, Benjamin Hawkins, Marco Liverani, Don Brown, Chris Holden, Aloisa Katsande, Neil Spicer, Preslava Stoeva Understanding Public Health is an innovative series published by Open University Press in collaboration with the London School of Hygiene & Tropical Medicine, where it is used as a key learning resource for postgraduate programmes. It provides self-directed learning covering the major issues in public health affecting low, middle and high income countries.  Series Editors: Rosalind Plowman and Nicki Thorogood.

This open access book provides a set of conceptual, empirical, and comparative chapters that apply a public policy perspective to investigate the political and institutional factors driving the use of evidence to inform health policy in low, middle, and high income settings. The work presents key findings from the Getting Research Into Policy (GRIP-Health) project: a five year, six country, programme of work supported by the European Research Council. The chapters further our understanding of evidence utilisation in health policymaking through the application of theories and methods from the policy sciences. They present new insights into the roles and importance of factors such as issue contestation, institutional arrangements, logics of appropriateness, and donor influence to explore individual cases and comparative experiences in the use of evidence to inform health policy.

This open access book provides a set of conceptual, empirical, and comparative chapters that apply a public policy perspective to investigate the political and institutional factors driving the use of evidence to inform health policy in low, middle, and high income settings. The work presents key findings from the Getting Research Into Policy (GRIP-Health) project: a five year, six country, programme of work supported by the European Research Council. The chapters further our understanding of evidence utilisation in health policymaking through the application of theories and methods from the policy sciences. They present new insights into the roles and importance of factors such as issue contestation, institutional arrangements, logics of appropriateness, and donor influence to explore individual cases and comparative experiences in the use of evidence to inform health policy.